Industries > Pharma > Generic Drugs Market Forecast 2019-2029

Generic Drugs Market Forecast 2019-2029

Growth in Leading Regional and National Markets – North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico, Teva, Novartis, Mylan, Pfizer, Abbott, Sun Pharma, Aspen, Fresenius Kabi, Sanofi, Dr. Reddy’s Laboratories Limited, Apotex

PUBLISHED: 14 June 2019
PAGES: 246
PRODUCT CODE: PHA0438
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1

The generic drugs market is estimated to have reached $257.3bn in 2018 and is expected to grow at a CAGR of 8.8% in the first half of the forecast period. Asia-Pacific held 31% of the generic drugs market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 246-page report you will receive 66 tables and 84 figures– all unavailable elsewhere.

The 246-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Generic Drugs Market forecasts from 2019-2029

• Generic Drugs Market forecasts from 2019-2029 by Regional and National Market:
• North America: U.S., Canada
• Europe: Germany, France, UK, Italy, Spain, Rest of Europe
• Asia-Pacific: Japan, China, Australia, South Korea, India, Rest of Asia-Pacific
• Middle East & Africa: South Africa, Saudi Arabia, UAE, Rest of Middle east & Africa
• Latin America: Brazil, Argentina, Mexico, Rest of Latin America

Generic Drugs Market Forecast 2019-2029

• Profiles and generic drugs revenue forecasts from 2019-2029 of these selected leading companies:
• Abbott
• Apotex
• Aspen
• Dr. Reddy’s Laboratories Limited
• Fresenius Kabi
• Mylan
• Novartis
• Pfizer
• Sanofi
• Sun Pharma
• Teva

• Qualitative analysis of the generic drugs market:
SWOT Analysis of the generic drugs market
Porter’s Five Forces Analysis of the generic drugs market
• Discussion on factors that drive and restrain the generic drugs market

• Key Questions Answered by This Report:
• How is the global market for generic drugs evolving?
• What are the major factors driving and restraining the generic drugs market dynamics?
• What were the market shares of the leading national markets in the global generic drugs market in 2018?
• How will each of these national markets grow over the forecast period and how much revenue will these markets account for by 2029?
• How will the market shares for each of the national markets develop from 2018 to 2029?
• Which particular national markets will be the main drivers of growth in the global market for generics from 2018 to 2029?
• How will political and regulatory factors influence the regional markets and submarkets?
• What are the predictions for partnerships, consolidation for existing players and the potential prospects for new market entrants?
• How will the industry sector evolve as legislations around patents and patent expiries change during the period between 2018 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the Generic Drugs Market. You find data, trends and predictions.

Buy our report today Global Generic Drugs Market Analysis : Forecast From 2019-2029 Growth in Leading Regional and National Markets – North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico, Teva, Novartis, Mylan, Pfizer, Abbott, Sun Pharma, Aspen, Fresenius Kabi, Sanofi, Dr. Reddy’s Laboratories Limited, Apotex.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Generic Drugs Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Generic Drugs Market Forecast 2019-2029


Latest Pharma news

Visiongain Publishes European Antibiotics Market Report 2021-2031

Penicillin segment holds majority of the market share owing to maximum prescription as well as the most generic manufacturers throughout the industry.

22 June 2021

READ

Visiongain Publishes Companion Diagnostics (CDx) Market Report 2021-2031

Over the last few years, companion diagnostics has gained widespread attention due to the technological advancements, growing demand for precision medicine, and accelerating demand for targeted therapy.

17 June 2021

READ

Visiongain Publishes Cellular Immunotherapy Market Report 2021-2031

Increasing prevalence of cancers and rising demand for advanced therapies for cancer treatment are the major factors driving the demand for cellular immunotherapies.

15 June 2021

READ

Visiongain Publishes Gene Therapy R&D Market Report 2021-2031

Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions.

14 June 2021

READ

Categories